Planet

The world we want tomorrow is a more sustainable world for people and pets. Using our influence to drive change at scale, we’re transforming our business in ways that protect the environment and drive positive change throughout the veterinary profession.

Mars Veterinary Health Positive Climate Action

We're taking climate action

By 2025, our goal is for 100% of our hospitals to be powered by renewable electricity. We’ve made recent progress by signing on to a power-purchase agreement between Mars and Apex Clean energy which will enable construction of a wind farm in Ford Ridge, IL. this agreement will provide clean electricity for our more than 2,000 veterinary hospitals across the U.S.

The turbines at Ford Ridge will generate enough electricity in one minute to power 36 veterinary visits and reduce CO2 by 11 pounds with each appointment. We are working with our UK and Europe based hospitals to source renewable electricity by 2025.

People, pets, and the planet: Mars Veterinary Health announces plans for 100% renewable electricity for all 2,000+ U.S. hospitals.

Read Article

Healthy Planet

Vet Tail

Climate
change

We are helping combat the climate crisis with a science-based approach to reduce emissions, source renewable electricity, and improve energy efficiency.

Vet Tail

Pharmaceutical
stewardship

We are committed to doing our part to protect the efficacy of antimicrobials through responsible use.

Vet Tail

Waste
Reduction

We aim to increasingly reduce our hospital waste by reducing the materials and packaging we use, reusing products when safe to do so, and an increasing recycling.

Preserving the power of antimicrobials

Antimicrobial resistance (AMR) and antibiotic prescribing are inextricably linked. As veterinary professionals, we play a vital role in reducing the need for antibiotics and limiting opportunities for antimicrobial-resistant strains to develop. Given incorrect use and overuse of antibiotics is a major driver of resistance, we are focused on assessing our use of antimicrobials and bolstering our approaches to responsible pharmaceutical stewardship, particularly in the fight against antibiotic-resistant bacteria.